Bladder cancer, Transitional cell cancer
Results
Phase 2
This trial looked at atezolizumab for people whose bladder cancer had spread beyond the inner lining of the bladder, but not to another area of the body.
Recruitment start: 1 May 2016
Recruitment end: 30 June 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Thomas Powles
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
F. Hoffmann-La Roche Ltd
Queen Mary University of London
This is the Cancer Research UK trial number CRUKE/15/014.
Last reviewed: 12 Mar 2021
CRUK internal database number: 13385